Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B D Evans

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Cancer Chemotherapy and Pharmacology|June 15, 1999
Metabolism of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in cancer patients undergoing a phase I clinical trialP C Schofield, I G Robertson, J W Paxton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancerI E Smith, B D Evans, M E Gore, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinomaI E Smith, B D Evans, S J Harland, et al.
European Journal of Cancer|January 1, 1980
Vindesine as a single agent and in combination with adriamycin in the treatment of metastatic breast carcinomaI E Smith, R C Coombes, B D Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancerD J Perez, V J Harvey, B A Robinson, et al.
Journal of Clinical Microbiology|February 1, 1994
Monoclonal antibody to native P39 protein from Borrelia burgdorferiT J Sullivan, K E Hechemy, H L Harris, et al.
Australian and New Zealand Journal of Medicine|June 1, 1995
Adjuvant chemotherapy for non-metastatic osteosarcoma of the extremities in two New Zealand cancer centresM B Jameson, B D Evans, D H Gray, et al.
The New Zealand Medical Journal|March 11, 1992
Ondansetron reduces chemotherapy induced nausea and vomiting refractory to standard antiemeticsP L Mitchell, B D Evans, S G Allan, et al.
Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology|December 18, 2016
Life in the fat lane: seasonal regulation of insulin sensitivity, food intake, and adipose biology in brown bearsK S Rigano, J L Gehring, B D Evans Hutzenbiler, et al.
Cancer Treatment Reports|January 1, 1985
Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancerI E Smith, S J Harland, B A Robinson, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|June 15, 1999
Metabolism of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in cancer patients undergoing a phase I clinical trialP C Schofield, I G Robertson, J W Paxton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancerI E Smith, B D Evans, M E Gore, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinomaI E Smith, B D Evans, S J Harland, et al.
European Journal of Cancer|January 1, 1980
Vindesine as a single agent and in combination with adriamycin in the treatment of metastatic breast carcinomaI E Smith, R C Coombes, B D Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancerD J Perez, V J Harvey, B A Robinson, et al.
Journal of Clinical Microbiology|February 1, 1994
Monoclonal antibody to native P39 protein from Borrelia burgdorferiT J Sullivan, K E Hechemy, H L Harris, et al.
Australian and New Zealand Journal of Medicine|June 1, 1995
Adjuvant chemotherapy for non-metastatic osteosarcoma of the extremities in two New Zealand cancer centresM B Jameson, B D Evans, D H Gray, et al.
The New Zealand Medical Journal|March 11, 1992
Ondansetron reduces chemotherapy induced nausea and vomiting refractory to standard antiemeticsP L Mitchell, B D Evans, S G Allan, et al.
Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology|December 18, 2016
Life in the fat lane: seasonal regulation of insulin sensitivity, food intake, and adipose biology in brown bearsK S Rigano, J L Gehring, B D Evans Hutzenbiler, et al.
Cancer Treatment Reports|January 1, 1985
Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancerI E Smith, S J Harland, B A Robinson, et al.
Pageof 7